Top 5 Medical Stocks To Invest In Right Now

Big Pharma has a new contender to worry about…

Tech giant Apple Inc. (Nasdaq: AAPL) has hired a small team of biomedical science engineers to develop revolutionary blood sugar sensors, according to an April 13 report by CNBC.

In fact, the team has been quietly developing the devices since before the death of former Apple CEO Steve Jobs.

If successful, the advance could help millions of diabetes patients and turn the Apple Watch – which the sensors are rumored to pair with – from a “nice to have” into a “must have.”

And now, at a time when Big Pharma has been put under the spotlight for exuberant drug costs, unfair pricing practices, and outrageous CEO behavior, Apple may be in the perfect position to snap up market share…

Top 5 Medical Stocks To Invest In Right Now: St. Jude Medical, Inc.(STJ)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Deutsche Bank upgraded shares of St. James’s Place (LON:STJ) to a buy rating in a research report released on Thursday. They currently have GBX 1,430 ($19.19) target price on the stock, up from their prior target price of GBX 1,310 ($17.58).

  • [By Stephan Byrd]

    Media headlines about St Jude Medical (NYSE:STJ) have been trending positive recently, according to Accern. Accern identifies positive and negative press coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. St Jude Medical earned a coverage optimism score of 0.26 on Accern’s scale. Accern also gave media coverage about the medical technology company an impact score of 46.7237518599623 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

Top 5 Medical Stocks To Invest In Right Now: General Employment Enterprises, Inc.(JOB)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Valeritas Holdings, Inc. (NASDAQ: VLRX) shares jumped 17 percent to $3.65.
    Cambium Learning Group, Inc. (NASDAQ: ABCD) shares rose 13.5 percent to $11.70.
    McDermott International, Inc. (NYSE: MDR) gained 11.6 percent to $6.75 after the UK-based offshore oil service company Subsea 7 made an unsolicited bid to buy McDermott for $7 per share. However, the acquisition offer is contingent on McDermot terminating its pending merger with Chicago Bridge & Iron Company.
    Nautilus, Inc. (NYSE: NLS) shares jumped 11.2 percent to $14.95. Nautilus is expected to release Q1 results on May 7, 2018. Craig-Hallum initiated coverage on Nautilus with a Buy rating and a $19.00 price target.
    GEE Group, Inc. (NYSE: JOB) shares gained 11 percent to $2.2199.
    Check-Cap Ltd. (NASDAQ: CHEK) surged 10.8 percent to $4.50.
    Foresight Autonomous Holdings Ltd (NASDAQ: FRSX) rose 10.1 percent to $3.39.
    Stars Group Inc. (NASDAQ: TSG) climbed 9.6 percent to $32.10. Stars Group Inc (NASDAQ: TSG) announced plans to acquire Sky Betting & Gaming for $4.7 billion.
    Insmed Incorporated (NASDAQ: INSM) shares jumped 9.1 percent to $25.66. Credit Suisse upgraded Insmed from Neutral to Outperform.
    Tennant Company (NYSE: TNC) rose 8.4 percent to $75.65 after the company posted upbeat Q1 results and raised its FY18 earnings outlook.
    Command Security Corporation (NYSE: MOC) shares gained 6.4 percent to $3.0960 after the company disclosed a $23 million five-year contract with LaGuardia Gateway Partners for LaGuardia Airport New Central Terminal Building.
    Helios and Matheson Analytics Inc. (NASDAQ: HMNY) rose 6.2 percent to $2.41 after falling 10.98 percent on Friday.
    Vectren Corporation (NYSE: VVC) shares rose 5.7 percent to $69.31. CenterPoint Energy, Inc. (NYSE: CNP) announced plans to acquire Vectren for $72 per share in cash.
    Hanesbrands Inc. (NYSE: HBI) gained 4.9 percent to $18.035. Stifel Nicolaus upgraded Hanesbrands from Hold to Buy.
    M
  • [By Lisa Levin] Gainers
    Check-Cap Ltd. (NASDAQ: CHEK) shares rose 78.82 percent to close at $7.26 on Monday.
    GEE Group, Inc. (NYSE: JOB) shares jumped 18 percent to close at $2.36.
    McDermott International, Inc. (NYSE: MDR) climbed 15.7 percent to close at $7.00 after the UK-based offshore oil service company Subsea 7 made an unsolicited bid to buy McDermott for $7 per share. However, the acquisition offer is contingent on McDermot terminating its pending merger with Chicago Bridge & Iron Company.
    Foresight Autonomous Holdings Ltd (NASDAQ: FRSX) gained 17.21 percent to close at $3.61.
    Stars Group Inc. (NASDAQ: TSG) rose 14.16 percent to close at $33.45. Stars Group Inc (NASDAQ: TSG) announced plans to acquire Sky Betting & Gaming for $4.7 billion.
    China Internet Nationwide Financial Services Inc. (NASDAQ: CIFS) shares jumped 12.79 percent to close at $25.58.
    Nautilus, Inc. (NYSE: NLS) shares gained 11.52 percent to close at $15.00. Nautilus is expected to release Q1 results on May 7, 2018. Craig-Hallum initiated coverage on Nautilus with a Buy rating and a $19.00 price target.
    Box, Inc. (NYSE: BOX) rose 10.94 percent to close at $22.91.
    Insmed Incorporated (NASDAQ: INSM) shares rose 10.76 percent to close at $26.05. Credit Suisse upgraded Insmed from Neutral to Outperform.
    NextDecade Corporation (NASDAQ: NEXT) shares rose 10.02 percent to close at $6.48.
    Helios and Matheson Analytics Inc. (NASDAQ: HMNY) shares gained 8.37 percent to close at $2.46 on Monday after falling 10.98 percent on Friday.
    Cambium Learning Group, Inc. (NASDAQ: ABCD) shares gained 7.81 percent to close at $11.11.
    Vectren Corporation (NYSE: VVC) shares rose 7.26 percent to close at $70.31. CenterPoint Energy, Inc. (NYSE: CNP) announced plans to acquire Vectren for $72 per share in cash.
    Tennant Company (NYSE: TNC) rose 6.66 percent to close at $74.45 after the company posted upbeat Q1 results and raised its FY18 earnings outlook.
    Hanesbrands Inc.
  • [By Lisa Levin] Gainers
    Blink Charging Co. (NASDAQ: BLNK) shares jumped 26.5 percent to $6.9042. Blink Charging reported Q1 net income of $2.2 million, versus a year-ago net loss of $3.1 million.
    Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) shares climbed 17.4 percent to $3.11. Eleven Biotherapeutics posted a Q1 loss of $0.11 per share.
    Flanigan's Enterprises, Inc. (NYSE: BDL) shares jumped 17 percent to $27.97 following Q2 results. Flanigan's Enterprises posted Q2 earnings of $0.75 per share on sales of $29.456 million.
    Borqs Technologies, Inc. (NASDAQ: BRQS) rose 15.8 percent to $8.05 after reporting Q1 results.
    Abaxis, Inc. (NASDAQ: ABAX) jumped 15.3 percent to $82.75. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash.
    21Vianet Group, Inc. (NASDAQ: VNET) gained 15.1 percent to $6.33.
    Gemphire Therapeutics Inc. (NASDAQ: GEMP) rose 13.8 percent to $6.27.
    Enphase Energy, Inc. (NASDAQ: ENPH) gained 12.8 percent to $5.98. H.C. Wainwright initiated coverage on Enphase Energy with a Buy rating.
    PetIQ Inc (NASDAQ: PETQ) shares surged 12.1 percent to $21.68 after reporting a first-quarter sales beat.
    NF Energy Saving Corporation (NASDAQ: NFEC) climbed 11.6 percent to $2.399.
    Allied Healthcare Products, Inc. (NASDAQ: AHPI) surged 11.4 percent to $3.0643.
    Boot Barn Holdings, Inc. (NYSE: BOOT) gained 11.1 percent to $24.40 after the company reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance.
    Ascena Retail Group, Inc. (NASDAQ: ASNA) rose 10.9 percent to $3.16.
    Sea Limited (NYSE: SE) gained 10.1 percent to $11.71 after reporting Q1 results.
    GEE Group, Inc. (NYSE: JOB) climbed 7.9 percent to $2.61 following Q2 results.
    The ONE Group Hospitality, Inc. (NASDAQ: STKS) gained 7.6 percent to $2.41 after reporting Q1 results.
    Biolinerx Ltd/S ADR (NASDAQ: BLRX) rose 7.3 percent to $0.8798 after the company was granted a patent approval. The clinical-st

Top 5 Medical Stocks To Invest In Right Now: Cinemark Holdings Inc(CNK)

Advisors’ Opinion:

  • [By Shane Hupp]

    Hodges Capital Management Inc. raised its stake in Cinemark Holdings, Inc. (NYSE:CNK) by 2.0% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 311,681 shares of the company’s stock after acquiring an additional 6,234 shares during the quarter. Hodges Capital Management Inc. owned approximately 0.27% of Cinemark worth $11,741,000 as of its most recent filing with the Securities & Exchange Commission.

  • [By Shane Hupp]

    Blair William & Co. IL raised its stake in Cinemark Holdings, Inc. (NYSE:CNK) by 6.4% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 31,906 shares of the company’s stock after purchasing an additional 1,929 shares during the period. Blair William & Co. IL’s holdings in Cinemark were worth $1,202,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

  • [By Shane Hupp]

    A number of institutional investors have recently added to or reduced their stakes in the business. Victory Capital Management Inc. increased its position in Cinemark by 73.2% during the fourth quarter. Victory Capital Management Inc. now owns 6,081,823 shares of the company’s stock worth $211,768,000 after buying an additional 2,570,923 shares in the last quarter. Rivulet Capital LLC increased its position in Cinemark by 88.0% during the fourth quarter. Rivulet Capital LLC now owns 2,859,216 shares of the company’s stock worth $99,558,000 after buying an additional 1,338,000 shares in the last quarter. River Road Asset Management LLC increased its position in Cinemark by 1.9% during the fourth quarter. River Road Asset Management LLC now owns 2,312,832 shares of the company’s stock worth $80,533,000 after buying an additional 42,982 shares in the last quarter. Bank of New York Mellon Corp increased its position in Cinemark by 4.0% during the fourth quarter. Bank of New York Mellon Corp now owns 1,728,543 shares of the company’s stock worth $60,187,000 after buying an additional 66,700 shares in the last quarter. Finally, Dimensional Fund Advisors LP increased its position in Cinemark by 3.4% during the third quarter. Dimensional Fund Advisors LP now owns 1,334,140 shares of the company’s stock worth $48,310,000 after buying an additional 43,606 shares in the last quarter. 94.03% of the stock is owned by institutional investors.

    ILLEGAL ACTIVITY WARNING: “$0.61 EPS Expected for Cinemark Holdings, Inc. (CNK) This Quarter” was published by Ticker Report and is the sole property of of Ticker Report. If you are viewing this story on another publication, it was illegally stolen and reposted in violation of United States & international copyright & trademark laws. The legal version of this story can be accessed at www.tickerreport.com/banking-finance/3362835/0-61-eps-expected-for-cinemark-holdings

  • [By Rich Smith]

    On balance, AMC’s offer still appears to fall significantly short of MoviePass’ as a value proposition (as did an earlier competing offer from Cinemark (NYSE:CNK) last year). So long as MoviePass remains in business, I honestly can’t see many moviegoers taking AMC up on its offer.

  • [By Shane Hupp]

    Royal Bank of Canada raised its holdings in Cinemark Holdings, Inc. (NYSE:CNK) by 10.4% during the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 110,946 shares of the company’s stock after purchasing an additional 10,434 shares during the quarter. Royal Bank of Canada’s holdings in Cinemark were worth $4,179,000 as of its most recent SEC filing.

Top 5 Medical Stocks To Invest In Right Now: Mesoblast Limited(MESO)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Shares of Mesoblast limited (NASDAQ:MESO) have been assigned an average recommendation of “Hold” from the nine ratings firms that are presently covering the stock, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a sell recommendation, one has issued a hold recommendation and five have assigned a buy recommendation to the company. The average 1 year price objective among brokerages that have issued ratings on the stock in the last year is $15.33.

Top 5 Medical Stocks To Invest In Right Now: IPG Photonics Corporation(IPGP)

Advisors’ Opinion:

  • [By Shane Hupp]

    Moors & Cabot Inc. raised its stake in IPG Photonics Co. (NASDAQ:IPGP) by 2.9% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 10,455 shares of the semiconductor company’s stock after buying an additional 295 shares during the period. Moors & Cabot Inc.’s holdings in IPG Photonics were worth $2,440,000 at the end of the most recent quarter.

  • [By Danny Vena, Timothy Green, and Rich Duprey]

    To help with that task, we asked three Motley Fool investors to choose companies that doubled in 2017 and evaluate their potential for future growth. They offered up their assessments of Micron Technology, Inc. (NASDAQ:MU), Weight Watchers International, Inc. (NYSE:WTW), and IPG Photonics Corporation (NASDAQ:IPGP).

  • [By Ethan Ryder]

    Princeton Capital Management LLC grew its position in IPG Photonics (NASDAQ:IPGP) by 3.6% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 11,998 shares of the semiconductor company’s stock after acquiring an additional 421 shares during the quarter. IPG Photonics accounts for about 1.2% of Princeton Capital Management LLC’s holdings, making the stock its 27th largest position. Princeton Capital Management LLC’s holdings in IPG Photonics were worth $2,800,000 at the end of the most recent reporting period.

Leave a Reply

Your email address will not be published. Required fields are marked *